424 related articles for article (PubMed ID: 16856544)
1. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Mio Y
Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
[TBL] [Abstract][Full Text] [Related]
2. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
[TBL] [Abstract][Full Text] [Related]
3. [Antinociceptive effects of landiolol and esmolol].
Masaki E
Masui; 2006 Jul; 55(7):849-55. PubMed ID: 16856545
[TBL] [Abstract][Full Text] [Related]
4. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.
Tanahashi S; Iida H; Dohi S; Oda A; Osawa Y; Yamaguchi S
Eur J Anaesthesiol; 2009 Mar; 26(3):196-200. PubMed ID: 19237982
[TBL] [Abstract][Full Text] [Related]
6. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
[TBL] [Abstract][Full Text] [Related]
8. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Kurosawa S; Kanaya N; Niiyama Y; Nakayama M; Fujita S; Namiki A
Can J Anaesth; 2003 May; 50(5):489-94. PubMed ID: 12734159
[TBL] [Abstract][Full Text] [Related]
9. The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Sugiura S; Seki S; Hidaka K; Masuoka M; Tsuchida H
Anesth Analg; 2007 Jan; 104(1):124-9. PubMed ID: 17179256
[TBL] [Abstract][Full Text] [Related]
10. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.
Yamakage M; Iwasaki S; Jeong SW; Satoh J; Namiki A
Heart Lung; 2009; 38(1):48-55. PubMed ID: 19150530
[TBL] [Abstract][Full Text] [Related]
11. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703
[TBL] [Abstract][Full Text] [Related]
12. [Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation].
Kawano T; Eguchi S; Iseki A; Oshita S
Masui; 2005 Jun; 54(6):610-4. PubMed ID: 15966376
[TBL] [Abstract][Full Text] [Related]
13. Landiolol, an ultra short-acting beta1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model.
Kurita T; Takata K; Uraoka M; Morita K; Sato S
Anesth Analg; 2007 Sep; 105(3):656-60. PubMed ID: 17717219
[TBL] [Abstract][Full Text] [Related]
14. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.
Oda Y; Nishikawa K; Hase I; Asada A
Anesth Analg; 2005 Mar; 100(3):733-737. PubMed ID: 15728061
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
[TBL] [Abstract][Full Text] [Related]
16. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
[TBL] [Abstract][Full Text] [Related]
18. Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Poveda-Jaramillo R; Monaco F; Zangrillo A; Landoni G
J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1415-1425. PubMed ID: 29398384
[TBL] [Abstract][Full Text] [Related]
19. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
20. [Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting].
Iwasawa K; Nakagawa H; Katou M; Yonezawa K; Nishizawa M; Yanagiya N
Masui; 2005 Apr; 54(4):402-7. PubMed ID: 15852628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
